# CHECKPOINT_2026-09-18T2238_COMMERCIAL

**Project:** FishAI  
**Checkpoint interval:** 4 hours (commercial-layer integration + claims remediation)  
**Issued:** 2026-09-18T22:38:00-07:00  
**Start time:** 2026-09-18T22:15:00-07:00  
**Elapsed hours:** **not invented here** — see `project_state.json` `elapsed_time` (unchanged by this agent)  
**State:** `STATE_10_PAUSED_FOR_HUMAN_DECISION`  
**Decision: PAUSE** — founder wedge lock required; customer-facing **model** claims halted; unsafe sample copy remediated in place.

No expansion, ingest, or ML until the founder answers `decision_required.md`.

---

## Ten questions

### 1. What do we know with high confidence?

- Configuration was not supplied; working name may be FishAI; FOUNDER_OR_ORGANIZATION is UNRESOLVED.
- HiveClaw/Atlas/NeuroClaw do not define this marine product.
- WoRMS IDs (accessed 2026-09-18): *Magallana gigas* 836033; *Oncorhynchus tshawytscha* 158075; *Homarus americanus* 156134.
- Specialist dossiers now exist for requirements, marine domain, rights, geospatial (design), quality/validation (protocol), product, scientific red team, and a **partial** data-discovery catalog.
- Red team: **no** customer-facing model; oyster 72h ops-stress is the least-bad scientific pilot **if** the food-safety wall holds; 2021 WA oyster kill was **atmospheric heat × midday emersion**, not SST.
- SST ≥ 19 °C is **not** a WA oyster mortality law (growth/clearance band). Totten is a 2026 Vp Category 3 harvest-control area and was an unsafe demo geography.
- Product sample brief and B4 expert rule have been **rewritten in place** (Willapa, Category D, air×tide×solar, 14 fields, hard DOH wall, HYPOTHESIS gates).
- USDA 2023: 114 WA Pacific oyster farms, $106.801 million sales. Maine DMR 2025 prelim. lobster: 78.8 million lb, $461.4 million. CA ocean salmon fully closed 2023–24.
- No data ingested; no ML; **zero interviews**.

### 2. What do we know with medium confidence?

- W1 Willapa oyster 72h **email/PDF ops-risk brief** is the best **starting** commercial test if the founder lacks operator relationships.
- NANOOS already shows water quality; FishAI must be a **decision brief**, not another map.
- W2 Cape Falcon–Humbug and W3 SA 513 are coherent if relationships exist; W2 is the weakest 24–48h science.
- PSI 20–80% summer mortality describes severe events, not a Willapa mean.
- A **manual** 14-day brief could test workflow after lock; it still needs an NSSP-literate reviewer before any real send.

### 3. What assumptions remain untested?

Operator decision reality; non-safety usefulness (growers may only want harvest-legal advice); WTP; outcome logging; NANOOS commercial reuse; Willapa vs South Puget Sound; captain/lobster data sharing; whether any temperature “stress” display is too close to Vp controls (public-health reviewer). See `assumptions_register.md`.

### 4. What critical data or rights gaps remain?

- No founder-selected species × geography × customer × decision.
- No partner outcome data; no DUA.
- No rights approval for ingest (NANOOS per-provider; DOH GIS; RecFIN; DMR microdata; GFW denied).
- Willapa in-situ thinner than Hood Canal ORCA.
- Data-discovery catalog incomplete.
- No named human domain reviewers.

### 5. What did we build or validate since the last checkpoint?

**Built (integration):** `artifacts/integration/COMMERCIAL_WEDGE_SYNTHESIS.md`, this checkpoint, `claims_remediation_log.md`; `project_state.json` updated without leaving STATE_10.  
**Patched:** product sample/wireframe/thesis/MVP/pilot offer; quality B4/B5 and related one-liners; requirements “safely work.”  
**Validated empirically:** nothing. Validation status = **PROTOCOL_ONLY**.

### 6. Did the product get closer to a customer decision?

**On paper only.** The 14-field Category D brief is now aligned with the prediction contract and is no longer a Totten/Vp-flavored mock. **No customer has seen a brief.** Model claims are **halted**.

### 7. Did we improve data quality, forecast validity, or customer utility?

No datasets, no forecasts, no utility measurement. Improved **claim safety** of internal samples and the expert-rule spec (wrong SST kill-law removed). Utility remains unmeasured.

### 8. Are we repeating low-value work?

Risk: more cataloging of the same three species without a lock. Integration should **stop** parallel research expansion. Do not open a fourth wedge.

### 9. Should we narrow scope?

**Yes, after founder pick.** Do not narrow unilaterally (would invent a founder choice). Do not expand. Recommended narrow: W1 Willapa, manual brief only.

### 10. What are the top three next actions?

1. **Founder wedge lock** + PRIMARY_OUTCOME_METRIC + geography lock (`decision_required.md` items 3, 8, 9, and 4/5/6).
2. Permissioned 8–15 interviews (`interview_script.md`); name human reviewers (oyster: shellfish + NSSP).
3. Only after (1): 14-day **manual** Category D brief for one design partner; rights review of that brief’s sources only; no ingest lake; no ML.

---

## Scores (0–5)

| Dimension | Score | Note |
| --- | --- | --- |
| Customer Pain Evidence | 3 | Industry events documented; no named-customer pain |
| Willingness-to-Pay Evidence | 0 | Zero interviews, pilots, or pricing tests |
| Data Rights Clarity | 3 | Register + matrix exist; **none** approved for ingest |
| Data Coverage/Quality | 3 | Public env/reg catalogs; labels missing; discovery incomplete |
| Ground Truth Availability | 1 | Path identified; no DUA or logs in hand |
| Baseline Feasibility | 3 | Air×emersion×wave B4 specified as **HYPOTHESIS**; not fitted; 19 °C SST kill-law removed |
| Model Lift Evidence | 0 | No model; customer-facing model claims halted |
| Validation Rigor | 2 | Protocol written; **not executed** (PROTOCOL_ONLY) |
| Product Actionability | 3 | 14-field Category D brief specified; not delivered |
| Defensibility/Data Flywheel | 1 | Outcome loop designed; zero partner data |
| Operational Complexity | 2 | Pipeline designed, not built; still no ingest (1 = simple, 5 = too complex) |
| Legal/Safety Risk | 4 | HIGH blockers still open: food-safety wall, ESA, lobster confidentiality, no human reviewer (5 = too risky) |

---

## Gate decision

**PAUSE**

- CONTINUE would require a locked wedge and a smallest **manual** experiment — not granted.
- NARROW is the post-approval move, not a unilateral lock.
- PIVOT is not evidenced (customers not heard).
- STOP (failure) is not triggered; this is the **configuration + claims-safety** pause.
- GO is **not** available: red team NO-GO for models; no interviews; no GT.

While paused, do not spend remaining budget on ingest, ML, a second species, or `observatory/` writes.
